v1
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
Identifier:nobleid.org/w1/20260515/5FCB7DBA
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →